The role of nanotechnology in the fight against COVID-19
Nanomedicine is a very powerful tool with the potential to mitigate the burden of disease by providing nanoparticle-based carriers and […]
COVID-19 (coronavirus disease 2019) is caused by a new positive-strand RNA coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), […] A team of scientists in Israel recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2 (also […] The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for […] Antidepressants could be prescribed by GPs as the new weapon in the war on Irritable Bowel Syndrome IBS affects 9m […] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. To date, […] Researchers have pinpointed a helper T cell population in the lungs of patients with severe COVID-19 that may be central […] Patients should be assessed for frailty before having many types of surgery, even if the surgery is considered low risk, […] Researchers in the United States and Canada have conducted a study showing that just a single dose of either the […] MONDAY, Oct. 5, 2020 — Adult patients with current or previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can develop […]syndrome
Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2
Data from Israel’s vaccination program suggests Pizer-BioNTech COVID-19 vaccine induces strong host antibody response
In-licensed candidate may be an effective intervention for preterm infants with respiratory distress syndrome
Antidepressants could be new weapon in war on Irritable Bowel Syndrome
Corticosteroid receptor inhibitor shows anti-SARS-CoV-2 activity in vivo
Hyperactive immune system contributes to COVID-19 severity, lung damage
Study: Patients should be assessed for frailty before considering multiple surgeries
Both mRNA vaccines protect against emerging variants of SARS-CoV-2
CDC Reports Cases of Multisystem Inflammatory Syndrome in Adults